Stock listing
ALVIO Stock Price, News, Filings & Events — Valerio Therapeutics
Selected listing: ALVIO · EURONEXT · EUR · FR
This page tracks Valerio Therapeutics's ALVIO:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVIO:EURONEXT. ALVIO:EURONEXT is the stock-level entry point for investors researching Valerio Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valerio Therapeutics is a public company traded under the ticker ALVIO on the French market. The company has a market capitalization of approximately €353.9 million. Valerio Therapeutics focuses on developing innovative therapeutic solutions.

- Ticker
- ALVIO:EURONEXT
- Asset type
- Stock
- Market cap
- $437.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR
Valerio Therapeutics ALVIO:EURONEXT stock context
This page tracks Valerio Therapeutics's ALVIO:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVIO:EURONEXT. ALVIO:EURONEXT is the stock-level entry point for investors researching Valerio Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valerio Therapeutics is a public company traded under the ticker ALVIO on the French market. The company has a market capitalization of approximately €353.9 million. Valerio Therapeutics focuses on developing innovative therapeutic solutions.
Research Valerio Therapeutics
Valerio Therapeutics investor report
Review AI stock analysis and investor report context for ALVIO:EURONEXT.
Valerio Therapeutics company profile
View the public company page for Valerio Therapeutics on 6ix.
Valerio Therapeutics news
Read company news and market updates connected to Valerio Therapeutics.
Valerio Therapeutics investor events
Find investor webinars, events, and replay context for Valerio Therapeutics.
Alternate listings
A0HMXA:LSX
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.
A0HMXA:LS
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.
0NWK:LSE
GB · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.
C4X:MUN
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.
C4X:GETTEX
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.
C4X:FWB
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.
C4X:SWB
DE · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.
ALVIOP:TURQUOISE
GB · EUR
Alternate listing for Valerio Therapeutics; the primary context on this page is ALVIO:EURONEXT.